North America Companion Diagnostics Market Size, Forecast: By Technology: Immunohistochemistry (IHC), Polymerase Chain Reaction (PCR), In-situ Hybridization (ISH), Real-time PCR (RT-PCR), Gene Sequencing, Others; By Indication: Lung Cancer, Breast Cancer, Others; By End User; Regional Analysis; Competitive Landscape; 2024-2032

1    Preface  
2    Report Coverage – Key Segmentation and Scope
3    Report Description
    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary
    5.1    Overview
    5.2    Key Drivers    
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Market Snapshot
7    Opportunities and Challenges in the Market
8    Global Companion Diagnostics Market Overview
    8.1    Key Industry Highlights
    8.2    Global Companion Diagnostics Historical Market (2017-2023) 
    8.3    Global Companion Diagnostics Market Forecast (2024-2032)
    8.4    Global Companion Diagnostics Market Share by Region
        8.4.1    North America
        8.4.2    Europe
        8.4.3    Asia Pacific
        8.4.4    Latin America
        8.4.5    Middle East and Africa
9    North America Companion Diagnostics Market Overview  
    9.1    Key Industry Highlights
    9.2    North America Companion Diagnostics Historical Market (2017-2023) 
    9.3    North America Companion Diagnostics Market Forecast (2024-2032)
10    North America Companion Diagnostics Market by Technology
    10.1    Immunohistochemistry (IHC)
        10.1.1    Historical Trend (2017-2023)
        10.1.2    Forecast Trend (2024-2032)
    10.2    Polymerase Chain Reaction (PCR)
        10.2.1    Historical Trend (2017-2023)
        10.2.2    Forecast Trend (2024-2032)
    10.3    In-situ Hybridization (ISH)
        10.3.1    Historical Trend (2017-2023)
        10.3.2    Forecast Trend (2024-2032)
    10.4    Real-time PCR (RT-PCR)
        10.4.1    Historical Trend (2017-2023)
        10.4.2    Forecast Trend (2024-2032)
    10.5    Gene Sequencing
        10.5.1    Historical Trend (2017-2023)
        10.5.2    Forecast Trend (2024-2032)
    10.6    Others
11    North America Companion Diagnostics Market by Indication​​​​​​​
    11.1    Lung Cancer
        11.1.1    Historical Trend (2017-2023)
        11.1.2    Forecast Trend (2024-2032)
    11.2    Breast Cancer
        11.2.1    Historical Trend (2017-2023)
        11.2.2    Forecast Trend (2024-2032)
    11.3    Colorectal Cancer
        11.3.1    Historical Trend (2017-2023)
        11.3.2    Forecast Trend (2024-2032)
    11.4    Leukaemia
        11.4.1    Historical Trend (2017-2023)
        11.4.2    Forecast Trend (2024-2032)
    11.5    Melanoma
        11.5.1    Historical Trend (2017-2023)
        11.5.2    Forecast Trend (2024-2032)
    11.6    Others
12    North America Companion Diagnostics Market by End User​​​​​​​
    12.1    Pharmaceutical and Biotechnology Companies
        12.1.1    Historical Trend (2017-2023)
        12.1.2    Forecast Trend (2024-2032)
    12.2    Reference Laboratories
        12.2.1    Historical Trend (2017-2023)
        12.2.2    Forecast Trend (2024-2032)
    12.3    Contract Research Organisations
        12.3.1    Historical Trend (2017-2023)
        12.3.2    Forecast Trend (2024-2032)
    12.4    Others
13    North America Companion Diagnostics Market by Country​​​​​​​
    13.1    United States of America
        13.1.1    Historical Trend (2017-2023)
        13.1.2    Forecast Trend (2024-2032)
    13.2    Canada
        13.2.1    Historical Trend (2017-2023)
        13.2.2    Forecast Trend (2024-2032)
14    Market Dynamics​​​​​​​
    14.1    SWOT Analysis
        14.1.1    Strengths
        14.1.2    Weaknesses
        14.1.3    Opportunities
        14.1.4    Threats
    14.2    Porter’s Five Forces Analysis
        14.2.1    Supplier’s Power
        14.2.2    Buyer’s Power
        14.2.3    Threat of New Entrants
        14.2.4    Degree of Rivalry
        14.2.5    Threat of Substitutes
    14.3    Key Indicators for Demand
    14.4    Key Indicators for Price
15    Competitive Landscape​​​​​​​
    15.1    Market Structure
    15.2    Company Profiles
        15.2.1    Quest Diagnostics Incorporated            
            15.2.1.1    Company Overview
            15.2.1.2    Product Portfolio
            15.2.1.3    Demographic Reach and Achievements
            15.2.1.4    Certifications
        15.2.2    Agilent Technologies, Inc.    
            15.2.2.1    Company Overview
            15.2.2.2    Product Portfolio
            15.2.2.3    Demographic Reach and Achievements
            15.2.2.4    Certifications
        15.2.3    F. Hoffmann-La Roche Ltd        
            15.2.3.1    Company Overview
            15.2.3.2    Product Portfolio
            15.2.3.3    Demographic Reach and Achievements
            15.2.3.4    Certifications
        15.2.4    Qiagen        
            15.2.4.1    Company Overview
            15.2.4.2    Product Portfolio
            15.2.4.3    Demographic Reach and Achievements
            15.2.4.4    Certifications
        15.2.5    Siemens AG        
            15.2.5.1    Company Overview
            15.2.5.2    Product Portfolio
            15.2.5.3    Demographic Reach and Achievements
            15.2.5.4    Certifications
        15.2.6    Thermo Fisher Scientific Inc    
            15.2.6.1    Company Overview
            15.2.6.2    Product Portfolio
            15.2.6.3    Demographic Reach and Achievements
            15.2.6.4    Certifications
        15.2.7    Laboratory Corporation of America Holdings            
            15.2.7.1    Company Overview
            15.2.7.2    Product Portfolio
            15.2.7.3    Demographic Reach and Achievements
            15.2.7.4    Certifications
        15.2.8    bioMérieux SA        
            15.2.8.1    Company Overview
            15.2.8.2    Product Portfolio
            15.2.8.3    Demographic Reach and Achievements
            15.2.8.4    Certifications
        15.2.9    Amgen Inc.            
            15.2.9.1    Company Overview
            15.2.9.2    Product Portfolio
            15.2.9.3    Demographic Reach and Achievements
            15.2.9.4    Certifications 
        15.2.10    Others
16    Key Trends and Developments in the Market  

List of Key Figures and Tables

1.    Global Companion Diagnostics Market: Key Industry Highlights, 2017 and 2032
2.    North America Companion Diagnostics Market: Key Industry Highlights, 2017 and 2032
3.    North America Companion Diagnostics Historical Market: Breakup by Technology (USD Billion), 2017-2023
4.    North America Companion Diagnostics Market Forecast: Breakup by Technology (USD Billion), 2024-2032
5.    North America Companion Diagnostics Historical Market: Breakup by Indication (USD Billion), 2017-2023
6.    North America Companion Diagnostics Market Forecast: Breakup by Indication (USD Billion), 2024-2032
7.    North America Companion Diagnostics Historical Market: Breakup by End User (USD Billion), 2017-2023
8.    North America Companion Diagnostics Market Forecast: Breakup by End User (USD Billion), 2024-2032
9.    North America Companion Diagnostics Historical Market: Breakup by Country (USD Billion), 2017-2023
10.    North America Companion Diagnostics Market Forecast: Breakup by Country (USD Billion), 2024-2032
11.    North America Companion Diagnostics Market Structure